Hypoxia-inducible factor-2α (HIF-2α) induces angiogenesis in breast carcinomas

被引:37
作者
Giatromanolaki, A
Sivridis, E
Fiska, A
Koukourakis, MI
机构
[1] Democritus Univ Thrace, Dept Pathol, Sch Med, Alexandroupolis, Greece
[2] Democritus Univ Thrace, Dept Anat, Sch Med, Alexandroupolis, Greece
[3] Democritus Univ Thrace, Dept Radiotherapy Oncol, Sch Med, Alexandroupolis, Greece
关键词
hypoxia-inducible factor-2 alpha; angiogenesis; c-erbB-2; metastasis; breast carcinomas;
D O I
10.1097/01.pai.0000145182.98577.10
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Hypoxia-inducible factors-1 alpha (HIF-1 alpha) and HIF-2 alpha are important proteins initiating tumor cell responses to hypoxia. Specifically, the transcription of genes related to erythropoiesis, glycolysis, and angiogenesis depends on the rate of HIF alpha binding to DNA at the hypoxia response elements of target genes. In this study, the authors evaluated the immunohistochemical expression of HIF-2 alpha in 62 infiltrating ductal carcinomas of the breast, not otherwise specified, in relation to estrogen and progesterone receptors, the MIB1 proliferation index, the vascular density, and the proteins c-erbB-2, bcl-2, and p53. Extensive and strong cytoplasmic and/or nuclear expression of HIF-2 alpha was noted in 23 of the 64 (35.9%) cases, and this was associated with increased vascular density (P = 0.0002), increased c-erbB-2 membrane expression (P = 0.02), and secondary deposits to multiple axillary lymph nodes (> 3). In multivariate analysis, HIF-2 alpha and T stage were the only variables related to extensive nodal metastasis. The authors conclude that HIF-2 alpha overexpression, a common event in infiltrating ductal carcinomas of the breast, is related to high metastatic potential via increased angiogenic and c-erbB-2 activity.
引用
收藏
页码:78 / 82
页数:5
相关论文
共 29 条
[21]   Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element [J].
Mazure, NM ;
Chen, EY ;
Laderoute, KR ;
Giaccia, AJ .
BLOOD, 1997, 90 (09) :3322-3331
[22]   C-ERBB-2 GENE-PRODUCT ASSOCIATES WITH CATENINS IN HUMAN CANCER-CELLS [J].
OCHIAI, A ;
AKIMOTO, S ;
KANAI, Y ;
SHIBATA, T ;
OYAMA, T ;
HIROHASHI, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 205 (01) :73-78
[23]   Hypoxia-inducible factor 1 alpha (HIF-1 alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions - Its stabilization by hypoxia depends on redox-induced changes [J].
Salceda, S ;
Caro, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (36) :22642-22647
[24]   Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1 [J].
Semenza, GL ;
Jiang, BH ;
Leung, SW ;
Passantino, R ;
Concordet, JP ;
Maire, P ;
Giallongo, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (51) :32529-32537
[25]   Association of hypoxia-inducible factors 1α and 2α with activated angiogenic pathways and prognosis in patients with endometrial carcinoma [J].
Sivridis, E ;
Giatromanolaki, A ;
Gatter, KC ;
Harris, AL ;
Koukourakis, MI .
CANCER, 2002, 95 (05) :1055-1063
[26]   The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages [J].
Talks, KL ;
Turley, H ;
Gatter, KC ;
Maxwell, PH ;
Pugh, CW ;
Ratcliffe, PJ ;
Harris, AL .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (02) :411-421
[27]   Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells [J].
Tian, H ;
McKnight, SL ;
Russell, DW .
GENES & DEVELOPMENT, 1997, 11 (01) :72-82
[28]   Induction of endothelial PAS domain protein-1 by hypoxia:: Characterization and comparison with hypoxia-inducible factor-1α [J].
Wiesener, MS ;
Turley, H ;
Allen, WE ;
Willam, C ;
Eckardt, KU ;
Talks, KL ;
Wood, SM ;
Gatter, KC ;
Harris, AL ;
Pugh, CW ;
Ratcliffe, PJ ;
Maxwell, PH .
BLOOD, 1998, 92 (07) :2260-2268
[29]  
Zhong H, 1998, CANCER RES, V58, P5280